Patent classifications
C12N15/8239
DISEASE RESISTANT POTATO PLANTS
The present invention relates to a plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin, wherein the plant has a reduced level, reduced activity or complete absence of DMR6 protein as compared to a plant that is not resistant to the said pathogen, in particular organisms of the Fungi or the phylum Oomycota. The invention further relates to a method for obtaining a plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin, comprising reducing the endogenous level or activity of DMR6 protein in the plant. In addition, the invention relates to the use of a DMR6 promotor for providing disease resistant plants.
Compositions and related methods for modulating transcriptional activation by incorporating GAG motifs upstream of core promoter elements
Compositions and methods for genetically modifying the production levels of nicotine and other alkaloids in plants are provided.
Disease resistant potato plants
The present invention relates to a plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin, wherein the plant has a reduced level, reduced activity or complete absence of DMR6 protein as compared to a plant that is not resistant to the said pathogen, in particular organisms of the Fungi or the phylum Oomycota. The invention further relates to a method for obtaining a plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin, comprising reducing the endogenous level or activity of DMR6 protein in the plant. In addition, the invention relates to the use of a DMR6 promotor for providing disease resistant plants.
CITRUS VARIETIES RESISTANT TO XANTHOMONAS CITRI INFECTION
The invention pertains to a plant cell or a plant having one or more mutations in the promoters of both the alleles for CsLOB1 gene, wherein the one or more mutations are in the promoter binding sites for PthA4 protein from Xanthomonas spp., and wherein the one or more mutations reduce or abolish the binding of the Xanthomonas spp. PthA4 protein on to the binding sites in the promoters of the CsLOB1 genes. Also, a plant cell or a plant having one or more mutations in the coding regions of both the alleles for CsLOB1 gene, wherein the one or more mutations reduce or abolish the binding of the function of CsLOB1 protein are provided. The invention further pertains to the methods of making the plant cell or the plant resistant to infection by Xanthomonas spp.
MODIFIED PLANTS AND METHODS OF DETECTING PATHOGENIC DISEASE
Genetically modified plants and methods of detecting diseases by a relevant color change in the genetically modified plant compared to a non-genetically modified plant are provided. Also disclosed is a system for remote detection of pathogens on crops and methods for treating crops under a pathogenic attack.
Compositions And Related Methods For Modulating Alkaloid Production By Controlling PMT Promoter Activation Mediated By Transcriptional Factors ERF and MYC
Compositions and methods for modifying the production levels of alkaloids in plants are provided. Alkaloid production can be genetically controlled by modulating the transcriptional activation of PMT genes mediated by members of the ERF family and/or Myc family of transcription factors. Novel nucleotide sequences encoding the Myc family of transcription factors are also provided.
MODULAR DNA-BINDING DOMAINS AND METHODS OF USE
The present invention refers to methods for selectively recognizing a base pair in a DNA sequence by a polypeptide, to modified polypeptides which specifically recognize one or more base pairs in a DNA sequence and, to DNA which is modified so that it can be specifically recognized by a polypeptide and to uses of the polypeptide and DNA in specific DNA targeting as well as to methods of modulating expression of target genes in a cell.
DISEASE RESISTANT BRASSICA PLANTS
The present invention relates to a mutant Brassica plant, which is resistant to a pathogen of viral, bacterial, fungal or oomycete origin. The mutant Brassica plant has a reduced level, reduced activity or complete absence of DMR6-1 protein and DMR6-2 protein as compared to a wild type Brassica plant.
Wound inducible expression construct and a method of its preparation
The present invention provides a wound inducible expression construct and a method of its preparation. The invention provides a methods for isolation of an early wound inducible promoter that is activated within 5 minutes of any form of wounding (mechanical or biological) and a process of making transgenic plants in which expression of GUS/Insecticidal protein is regulated by Promoter (I.D.1) in a wound inducible manner for local expression of a chimeric gene used in this method and plants obtained thereby, and to the process for obtaining resistance to insect feeding.
Compositions and related methods for modulating alkaloid production by controlling PMT promoter activation mediated by transcriptional factors ERF and MYC
Compositions and methods for modifying the production levels of alkaloids in plants are provided. Alkaloid production can be genetically controlled by modulating the transcriptional activation of PMT genes mediated by members of the ERF family and/or Myc family of transcription factors. Novel nucleotide sequences encoding the Myc family of transciption factors are also provided.